Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
national_influenza_vaccine_task_force [2022/10/12 22:45] liam | national_influenza_vaccine_task_force [2022/10/12 22:52] (current) liam [Further links to sort] |
---|
| |
===== History ===== | ===== History ===== |
| |
| {{ ::d8e63bb2226aa757f3d687b57e59783ebac637b0.jpeg?200|}} |
| |
On September 19, 2019, [[United States]] President [[Donald Trump]] issued [[Executive Order]] (EO) 13887: //Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health.//((Trump, D. J. (2019, September 19). //Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health.// The White House. https://archive.ph/5j8Zo)) The primary action of the EO was to create a National Influenza Vaccine Task Force in anticipation of an upcoming [[pandemic]], focusing on ramping up "innovative, faster, and more scaleable technologies" than was previously used for [[influenza vaccines]]. | On September 19, 2019, [[United States]] President [[Donald Trump]] issued [[Executive Order]] (EO) 13887: //Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health.//((Trump, D. J. (2019, September 19). //Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health.// The White House. https://archive.ph/5j8Zo)) The primary action of the EO was to create a National Influenza Vaccine Task Force in anticipation of an upcoming [[pandemic]], focusing on ramping up "innovative, faster, and more scaleable technologies" than was previously used for [[influenza vaccines]]. |
| |
{{ ::d8e63bb2226aa757f3d687b57e59783ebac637b0.jpeg?400|}} | |
| |
It additionally called for development and strengthening of [[public-private partnerships]], including the transfer of technology to such partnerships, specifically mentioning the [[HHS Centers for Innovation in Advanced Development and Manufacturing]]. Shortly after, in December 2019, the [[National Institute of Allergy and Infectious Diseases]] (NIAID) and [[pharmaceutical_companies:Moderna]] signed an agreement to transfer their jointly-owned [[mRNA vaccines|mRNA vaccine]] candidates to the [[University of North Carolina at Chapel Hill]].((//Secret Docs Reveal Moderna Sent Coronavirus Vaccine To North Carolina University Weeks Before Pandemic.// (2021, June 20). GreatGameIndia. https://web.archive.org/web/20220531014844/https://greatgameindia.com/moderna-vaccine-north-carolina-university/)) | It additionally called for development and strengthening of [[public-private partnerships]], including the transfer of technology to such partnerships, specifically mentioning the [[HHS Centers for Innovation in Advanced Development and Manufacturing]]. Shortly after, in December 2019, the [[National Institute of Allergy and Infectious Diseases]] (NIAID) and [[pharmaceutical_companies:Moderna]] signed an agreement to transfer their jointly-owned [[mRNA vaccines|mRNA vaccine]] candidates to the [[University of North Carolina at Chapel Hill]].((//Secret Docs Reveal Moderna Sent Coronavirus Vaccine To North Carolina University Weeks Before Pandemic.// (2021, June 20). GreatGameIndia. https://web.archive.org/web/20220531014844/https://greatgameindia.com/moderna-vaccine-north-carolina-university/)) |
| |
In August 2020, the task force published a report titled //National Influenza Vaccine Modernization Strategy 2020-2030//.((National Influenza Vaccine Task Force. (2020, August 28). //National Influenza Vaccine Modernization Strategy 2020-2030.// Office of the Assistant Secretary for Preparedness and Response. https://archive.ph/L2I4o)) | In August 2020, the task force published a report titled //National Influenza Vaccine Modernization Strategy 2020-2030//.((National Influenza Vaccine Task Force. (2020, August 28). //National Influenza Vaccine Modernization Strategy 2020-2030.// Office of the Assistant Secretary for Preparedness and Response. https://archive.ph/L2I4o)) |
| |
| ===== Organization ===== |
| |
| ==== Members ==== |
| |
| The task force is co-chaired by the Secretaries of Defense and Health and Human Services, or their designees. Its main membership includes representatives from a variety of key federal agencies: |
| |
| * [[Biomedical Advanced Research and Development Authority]] (BARDA) |
| * [[Centers for Disease Control and Prevention]] (CDC) |
| * [[Centers for Medicare and Medicaid Services]] (CMS) |
| * [[United States Department of Agriculture|Department of Agriculture]] (DOA) |
| * [[United States Department of Defense|Department of Defense]] (DOD) |
| * [[United States Department of Homeland Security|Department of Homeland Security]] (DHS) |
| * [[United States Department of Justice|Department of Justice]] (DOJ) |
| * [[United States Department of Veterans Affairs|Department of Veterans Affairs]] (VA) |
| * [[Food and Drug Administration]] (FDA) |
| * [[National Institutes of Health]] (NIH) |
| |
| Additional participants include: |
| |
| * [[Council of Economic Advisors]] |
| * [[United States Department of State|Department of State]] (DOS) |
| * [[Domestic Policy Council]] |
| * [[National Economic Council]] |
| * [[National Security Council]] (NSC) |
| * [[Office of Management and Budget]] (OMB) |
| * [[Office of Science and Technology Policy]] (OSTP) |
| |
| ===== Further links to sort ===== |
| |
| * [[https://www.cdc.gov/flu/prevent/advances.htm]] |
| * [[https://georgewebb.substack.com/p/chasing-corona]] |